TipRanks
Go Ultimate55% OFF

Easton Pharmaceuticals (EAPH) Income Statement

Easton Pharmaceuticals Income Statement

Last quarter (Q3 2021), Easton Pharmaceuticals's total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q3, Easton Pharmaceuticals's net income was $-84.35K. See Easton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 20Dec 19Dec 18
$ 0.00$ 1.56M$ 378.59K
$ 0.00$ 201.40K$ 106.91K
$ 188.54K$ 523.57K$ 231.13K
Depreciation and Amortization$ 180.67K$ 316.41K$ 119.06K
$ -8.33K$ -6.59K$ -4.94K
$ -189.00K$ -322.00K$ -124.00K
$ 0.00$ -1.00K$ -45.00K
$ -189.00K$ -323.00K$ -169.00K
$ -189.00K$ -323.00K$ -169.00K
Per Share Metrics
Basic EPS$ 0.00$ 0.00$ -0.00
Diluted EPS$ 0.00$ 0.00$ -0.00
Weighted Average Shares Outstanding1.34B1.34B1.21B
Weighted Average Shares Outstanding (Diluted)1.34B1.34B1.21B

Currency in USD

Easton Pharmaceuticals Earnings and Revenue History

-1M01M2M-48 %-36 %-24 %-12 %EarningsProfit Margin201820192020RevenueEarningsProfit Margin